XML 33 R26.htm IDEA: XBRL DOCUMENT v3.21.1
Summary of Significant Accounting Policies (Details Narrative) - USD ($)
12 Months Ended
Dec. 31, 2020
Dec. 31, 2019
Allowance for doubtful accounts $ 0 $ 0
Research and development cost 114,559 218,919
Loss on impairment 0 (69,178)
Uncertain tax positions 0 0
Cash equivalents $ 0 $ 0
Warrants    
Antidilutive Excluded from Computation of Earnings Per Share, Amount 950,000 975,000
Option    
Antidilutive Excluded from Computation of Earnings Per Share, Amount 12,180,500